D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 62 Citations 12,709 270 World Ranking 1844 National Ranking 111

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Philippe Morlat focuses on Internal medicine, Immunology, Acquired immunodeficiency syndrome, Hepatitis C and Gastroenterology. His Internal medicine research includes themes of Surgery and Viral load. His work deals with themes such as Protease inhibitor, Cause of death and Virology, which intersect with Immunology.

He specializes in Acquired immunodeficiency syndrome, namely Sida. His Hepatitis C research incorporates themes from Hepatitis B, Hepatocellular carcinoma and Hepatitis C virus. His Gastroenterology research is multidisciplinary, incorporating elements of Metabolic disorder, Interquartile range, Adverse effect, Quartile and Didanosine.

His most cited work include:

  • Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration (552 citations)
  • HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. (322 citations)
  • Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS (313 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Immunology, Cohort, Acquired immunodeficiency syndrome and Sida. The various areas that Philippe Morlat examines in his Internal medicine study include Gastroenterology, Surgery and Viral load. Many of his studies on Immunology apply to Risk factor as well.

The concepts of his Cohort study are interwoven with issues in Incidence, Hazard ratio, Confidence interval, Proportional hazards model and Coinfection. He works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to topics relating to Cause of death and, in certain cases, Liver disease, as a part of the same area of interest. His Hepatitis C study integrates concerns from other disciplines, such as Hepatocellular carcinoma and Hepatitis C virus.

He most often published in these fields:

  • Internal medicine (47.78%)
  • Immunology (25.94%)
  • Cohort (22.18%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (47.78%)
  • Cohort (22.18%)
  • Viral load (11.26%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cohort, Viral load, Hepatitis C virus and Immunology. Philippe Morlat regularly links together related areas like Gastroenterology in his Internal medicine studies. His Cohort research incorporates elements of Acquired immunodeficiency syndrome, Confidence interval, Proportional hazards model, Coinfection and Cannabis.

His work in Viral load addresses subjects such as Interquartile range, which are connected to disciplines such as Efavirenz, Pharmacogenetics and Single-nucleotide polymorphism. His CD8, Immune system and Interleukin 6 study in the realm of Immunology connects with subjects such as Case management. His research in Sida focuses on subjects like Hepatocellular carcinoma, which are connected to Cause of death and Mortality rate.

Between 2014 and 2021, his most popular works were:

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. (155 citations)
  • Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study (103 citations)
  • Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial (58 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

His scientific interests lie mostly in Internal medicine, Cohort, Immunology, Cohort study and Randomized controlled trial. The study incorporates disciplines such as Smoking cessation and Reverse-transcriptase inhibitor in addition to Internal medicine. Philippe Morlat has included themes like Cross-sectional study, Physical therapy, Cognitive decline and Confidence interval in his Cohort study.

His Immunology research focuses on CD8 in particular. Philippe Morlat focuses mostly in the field of Cohort study, narrowing it down to matters related to Prospective cohort study and, in some cases, Hazard ratio, Public health, Pregnancy and Pediatrics. His Cause of death research is multidisciplinary, incorporating perspectives in Mortality rate, Malignancy and Epidemiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)

924 Citations

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua.
International Journal of Epidemiology (2004)

504 Citations

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi.
Journal of Acquired Immune Deficiency Syndromes (2007)

496 Citations

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

Dominique Salmon-Ceron;Charlotte Lewden;Philippe Morlat;Sibylle Bévilacqua.
Journal of Hepatology (2005)

457 Citations

Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine

B Dannemann;J A McCutchan;D Israelski;D Antoniskis.
Annals of Internal Medicine (1992)

437 Citations

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Charlotte Lewden;Thierry May;Eric Rosenthal;Christine Burty.
Journal of Acquired Immune Deficiency Syndromes (2008)

434 Citations

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

Eric Rosenthal;Marilyne Poirée;Christian Pradier;Christian Perronne.
AIDS (2003)

360 Citations

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Fabrice Bonnet;Fabrice Bonnet;Charlotte Lewden;Thierry May M.D.;Laurence Heripret.
Cancer (2005)

343 Citations

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study

Lene Ryom;Amanda Mocroft;Ole Kirk;Ole Kirk;Signe W Worm.
The Journal of Infectious Diseases (2013)

341 Citations

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave.
Lancet Infectious Diseases (2017)

326 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philippe Morlat

Dominique Costagliola

Dominique Costagliola

Sorbonne University

Publications: 92

François Dabis

François Dabis

University of Bordeaux

Publications: 82

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 78

Geneviève Chêne

Geneviève Chêne

University of Bordeaux

Publications: 72

Caroline Sabin

Caroline Sabin

University College London

Publications: 72

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 70

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 68

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 64

Cécile Goujard

Cécile Goujard

University of Paris-Saclay

Publications: 62

Amy C. Justice

Amy C. Justice

Yale University

Publications: 57

Rodolphe Thiébaut

Rodolphe Thiébaut

Grenoble Alpes University

Publications: 54

Marina B. Klein

Marina B. Klein

University of British Columbia

Publications: 53

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 52

Michael S. Saag

Michael S. Saag

University of Alabama at Birmingham

Publications: 51

Christine Rouzioux

Christine Rouzioux

Necker-Enfants Malades Hospital

Publications: 51

Matthew Law

Matthew Law

University of New South Wales

Publications: 49

Trending Scientists

Steven J. E. Wilton

Steven J. E. Wilton

University of British Columbia

Sung-jin Kim

Sung-jin Kim

LG Electronics

Kenneth D. Karlin

Kenneth D. Karlin

Johns Hopkins University

Robert E. Huie

Robert E. Huie

National Institute of Standards and Technology

Yingjun Wang

Yingjun Wang

South China University of Technology

Thomas P. Sullivan

Thomas P. Sullivan

University of British Columbia

John E. Heckels

John E. Heckels

University of Southampton

Dean C. Crick

Dean C. Crick

Colorado State University

Andras Kapus

Andras Kapus

University of Toronto

Matthew H. Alford

Matthew H. Alford

University of California, San Diego

Grant A. McArthur

Grant A. McArthur

Peter MacCallum Cancer Centre

Peter Rossing

Peter Rossing

University of Copenhagen

Glenys Parry

Glenys Parry

University of Sheffield

Dennis McCarty

Dennis McCarty

Oregon Health & Science University

Edward Shils

Edward Shils

University of Chicago

Huan Lin

Huan Lin

Fermilab

Something went wrong. Please try again later.